Stock GVS GVS S.P.A.
Add to a list
To use this feature you must be a member
Log inSign up

Financials GVS S.p.A.

Equities

GVS

IT0005411209

Medical Equipment, Supplies & Distribution

Market Closed - Borsa Italiana
Other stock markets
 11:44:59 2024-06-28 EDT 		5-day change 1st Jan Change
6.57 EUR -0.15% Intraday chart for GVS S.p.A. -3.67% +17.85%
06-14 Mib down; political instability weakens euro AN
06-04 Futures down; focus on ECB cuts AN

Valuation

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 2,669 1,847 706.9 974.4 1,150 - -
Enterprise Value (EV) 1 2,642 1,943 706.9 1,303 1,428 1,375 1,327
P/E ratio - - 28.9 x 69.7 x 30.3 x 20.8 x 17.6 x
Yield 0.85% - - - - 1.11% 1.82%
Capitalization / Revenue 7.35 x 5.38 x 1.8 x 2.25 x 2.59 x 2.44 x 2.31 x
EV / Revenue 7.27 x 5.66 x 1.8 x 3.01 x 3.22 x 2.92 x 2.66 x
EV / EBITDA 18.3 x 18 x 8.95 x 13.7 x 13.3 x 10.8 x 9.43 x
EV / FCF - - - 17.8 x 33.8 x 21.2 x 18.7 x
FCF Yield - - - 5.63% 2.95% 4.71% 5.34%
Price to Book - - - - 3.13 x 2.66 x 2.4 x
Nbr of stocks (in thousands) 175,000 175,067 174,550 174,773 174,759 - -
Reference price 2 15.25 10.55 4.050 5.575 6.580 6.580 6.580
Announcement Date 21-03-19 22-03-22 23-03-21 24-03-26 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net sales 1 363.3 343.1 392 432.4 443.2 471 498.7
EBITDA 1 144.1 107.9 79 95.05 107.7 127.5 140.7
EBIT 1 128.6 89.3 54.8 67.42 79.62 98.05 110
Operating Margin 35.4% 26.03% 13.98% 15.59% 17.96% 20.82% 22.07%
Earnings before Tax (EBT) 1 - - 34.6 18.32 52 76 89.5
Net income 1 - - 24.1 13.64 38 55.65 65.8
Net margin - - 6.15% 3.16% 8.57% 11.81% 13.19%
EPS 2 - - 0.1400 0.0800 0.2170 0.3170 0.3740
Free Cash Flow 1 - - - 73.39 42.2 64.8 70.85
FCF margin - - - 16.98% 9.52% 13.76% 14.21%
FCF Conversion (EBITDA) - - - 77.21% 39.18% 50.81% 50.36%
FCF Conversion (Net income) - - - 537.99% 111.05% 116.44% 107.67%
Dividend per Share 2 0.1300 - - - - 0.0733 0.1200
Announcement Date 21-03-19 22-03-22 23-03-21 24-03-26 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 S1 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 S1 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 81.53 - - 116 104.9 109.4 213.4 99.74 119.2 103.9 108.6 108.1 119.1 112.4
EBITDA - - - - 22.6 - - 21.64 25.97 24.3 - - - -
EBIT - - - - 12.1 - - 15.23 18.41 13.1 - - - -
Operating Margin - - - - 11.53% - - 15.27% 15.44% 12.61% - - - -
Earnings before Tax (EBT) - - - - - - - - - - - - - -
Net income - 32.44 12.64 - 2.5 - - 8.469 -2.178 9.4 - - - -
Net margin - - - - 2.38% - - 8.49% -1.83% 9.05% - - - -
EPS - 0.1900 0.0700 - - - - - - - - - - -
Dividend per Share - - - - - - - - - - - - - -
Announcement Date 22-03-22 22-07-30 22-11-11 23-03-21 23-05-15 23-09-07 23-09-07 23-11-09 24-03-26 24-05-14 - - - -
1EUR in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - 96.5 - 329 278 225 177
Net Cash position 1 26.7 - - - - - -
Leverage (Debt/EBITDA) - 0.8944 x - 3.458 x 2.585 x 1.763 x 1.258 x
Free Cash Flow 1 - - - 73.4 42.2 64.8 70.9
ROE (net income / shareholders' equity) - - - 4.12% - - -
ROA (Net income/ Total Assets) - - - - - - -
Assets 1 - - - - - - -
Book Value Per Share 2 - - - - 2.100 2.480 2.750
Cash Flow per Share 2 - - - 0.6000 -0.0100 0.2600 0.2900
Capex 1 - - - 28.2 36.5 28.4 29.7
Capex / Sales - - - 6.52% 8.23% 6.02% 5.95%
Announcement Date 21-03-19 22-03-22 23-03-21 24-03-26 - - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for GVS S.p.A.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
6.58 EUR
Average target price
6.967 EUR
Spread / Average Target
+5.88%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Medical Supplies

1st Jan change Capi.
GVS S.P.A. Stock GVS S.p.A.
+17.85% 1.23B
COLOPLAST A/S Stock Coloplast A/S
+8.37% 27.11B
HARTALEGA HOLDINGS Stock Hartalega Holdings
+21.48% 2.35B
INTCO MEDICAL TECHNOLOGY CO., LTD. Stock Intco Medical Technology Co., Ltd.
+14.77% 2.35B
SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED Stock Shandong Weigao Group Medical Polymer Company Limited
-51.12% 2.22B
WINNER MEDICAL CO., LTD. Stock Winner Medical Co., Ltd.
-32.08% 2.03B
TOP GLOVE CORPORATION BHD. Stock Top Glove Corporation Bhd.
+22.22% 1.82B
HARBIN FUERJIA TECHNOLOGY CO., LTD. Stock Harbin Fuerjia Technology Co., Ltd.
-18.71% 1.74B
NAKANISHI INC. Stock Nakanishi Inc.
+7.63% 1.33B
KOSSAN RUBBER INDUSTRIES Stock Kossan Rubber Industries
+27.03% 1.23B
Medical Supplies
  1. Stock Market
  2. Equities
  3. GVS Stock
  4. Financials GVS S.p.A.